Drug Discovery For Tropical Diseases
- Assets
- $391.5k
- Revenue
- $618.1k
- Investments
- $0.0
- Employees
- 7
- Location
- San Diego, CA
- Founding
- 08/2011
- Data as of
- 12/2021
- EIN
- 27-4482027
Organization Overview
Drug Discovery For Tropical Diseases is located in San Diego, CA. The organization was established in 2011. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2021, Drug Discovery For Tropical Diseases employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Drug Discovery For Tropical Diseases is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Drug Discovery For Tropical Diseases generated $618.1k in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 34.4% each year . All expenses for the organization totaled $738.6k during the year ending 12/2021. While expenses have increased by 41.9% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
DELIVER NEW DRUGS AND NEW DIAGNOSTICS FOR DISEASES THAT AFFECT PREDOMINANTLY ECONOMICALLY VULNERABLE POPULATIONS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH WORK FOR DIAGNOSTICS TO DETECT BURULI ULCER, RIVER BLINDNESS, AND OTHER NEGLECTED TROPICAL DISEASES. IN 2021 ALL PROGRAMS WERE ALL AIMED AT GENERATING RAPID DIAGNOSTIC TESTS FOR LOW-TO-MIDDLE INCOME COUNTRIES. DEVELOPED RAPID TESTS FOR RIVER BLINDNESS (18 MILLION CASES), BURULI ULCER (100 THOUSAND CASES), AND LYMPHATIC FILARIASIS (40 MILLION CASES).
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Marco A Biamonte President | OfficerTrustee | 40 | $82,077 |
Vish Gaitonde Treasurer | OfficerTrustee | 0.5 | $0 |
Beverly Coyne Secretary | OfficerTrustee | 1 | $0 |
Robert Epple Director | Trustee | 0.5 | $0 |
Josh Salisbury Director | Trustee | 2 | $0 |
Matthew Waxman Director | Trustee | 5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $86,838 |
| Related organizations | $0 |
| Government grants | $58,774 |
| All other contributions, gifts, grants, and similar amounts not included above | $487,204 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $632,816 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$17,760 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $618,124 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $82,077 |
| Compensation of current officers, directors, key employees. | $32,831 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $296,275 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $37,430 |
| Payroll taxes | $24,509 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $6,893 |
| Fees for services: Accounting | $1,200 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $109,486 |
| Advertising and promotion | $0 |
| Office expenses | $26,210 |
| Information technology | $7,032 |
| Royalties | $0 |
| Occupancy | $59,952 |
| Travel | $1,424 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $14,085 |
| Insurance | $2,047 |
| All other expenses | $1,850 |
| Total functional expenses | $738,573 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $308,450 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $83,010 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $391,460 |
| Accounts payable and accrued expenses | $1,040 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $491 |
| Total liabilities | $1,531 |
| Net assets without donor restrictions | $389,929 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $391,460 |
Grants Recieved
Over the last fiscal year, we have identified 2 grants that Drug Discovery For Tropical Diseases has recieved totaling $366,686.
| Awarding Organization | Amount |
|---|---|
Foundation For Innovative New Diagnostics Find PURPOSE: Developmentandcommercialisationofdiagnotic tests | | $360,186 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $6,500 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Chan Zuckerberg Biohub Inc San Francisco, CA | $338,316,919 | $10,314,755 |
Critical Path Institute Tucson, AZ | $19,962,086 | $31,176,116 |
Medicines360 San Francisco, CA | $84,365,229 | $12,024,199 |
Research Corporation Tucson, AZ | $242,008,144 | $26,138,153 |
Southwest Autism Research And Resource Center Phoenix, AZ | $18,925,029 | $16,667,407 |
Conard House Inc San Francisco, CA | $5,907,710 | $14,988,369 |
Hopelab Foundation Inc San Francisco, CA | $32,085,472 | $14,961,821 |
Multidisciplinary Association For Psychedelic Studies San Jose, CA | $92,188,866 | $23,580,425 |
Glenn Foundation For Medical Research Inc Phoenix, AZ | $192,520,690 | $23,653,368 |
Hmsa Foundation Honolulu, HI | $18,488,325 | $337,265 |
Larry L Hillblom Foundation Inc Petaluma, CA | $157,022,260 | $9,255,919 |
Arastradero Research Institute Palo Alto, CA | $86,734,431 | $15,446,292 |